News

November 17, 2016 - Diazon Pharmaceutical’s anti-cancer agent DZ-2384 mechanism for high activity and low neurotoxicity published by McGill researchers in Science Translational Medicine Read More

November 16, 2016 - Glycomine, Inc. Announces $12 Million Series A Financing to Advance a New Generation of Replacement Therapies for Rare Diseases Read More

November 15, 2016 - San Francisco VA, UCSF And CalciMedica, Inc. Present Results On CRAC Channel Inhibitors In Traumatic Brain Injury Model At Neuroscience Meeting Read More

November 14, 2016 - CalciMedica Announces Senior Clinical Development Hire Read More

November 10, 2016 - DalCor Announces Data to be Presented at the American Heart Association Scientific Sessions 2016 in New Orleans Read More

November 4, 2016 - ViaCyte to Present at Healthcare Events in November Read More

October 19, 2016 - Lineagen Announces Launch of Proprietary Variant Index to Improve Interpretation of Genetic Basis for Childhood Developmental Delay Read More

October 11, 2016 - ViaCyte to Present at Healthcare Events in October Read More

October 4, 2016 - Altor BioScience Corporation and NantKwest Inc. Announce Co-Development Agreement to Advance Innovative Natural Killer Cell Combination Immunotherapies for the Treatment of Cancer Read More

October 3, 2016 - THVD-102 Demonstrates Promising Potential as an Orally Administered Treatment for Hyperhidrosis Read More